Norges Bank purchased a new position in AbbVie stock, leading to a required institutional holdings disclosure filed with the SEC on July 2, 2026.
5 reports, 3 independent
Updated Sep 13
Gone quiet
- Reports
- 5
- Developments
- 4
- Repetition
- 20%
New informationRepeats or wire copies
AI-generated analysis. Brind wrote this summary from the reports listed below. It can be wrong. Each section says how much you can rely on it, and the sources are linked so you can check.
What happened
Norges Bank purchased a new position in AbbVie stock, leading to a required institutional holdings disclosure filed with the SEC on July 2, 2026.
Who's involved
What this event is mainly aboutHow it developed
Newest first. Tap a step to see who reported it.Norges Bank made a subsequent purchase of AbbVie stock.1 source
Norges Bank made another new purchase of AbbVie shares.1 source
Norges Bank bought a new stake in AbbVie on July 9, 2026.1 source
Norges Bank purchased a new position in AbbVie stock, leading to a required institutional holdings disclosure filed with the SEC on July 2, 2026.1 source
Keep exploring
The entities involved
-
AbbVie
pharmaceutical company
-
Norges Bank
central bank of Norway
-
Securities and Exchange Commission
government agency of the Philippines
Related events
- Source Capital, Inc. filed required documents with the Securities and Exchange Commission regarding institutional ownership changes.
- Novo Nordisk filed required documents with the SEC regarding stock changes on October 22, 2026.
- Iron Horse Acquisitions II Corp. filed disclosures with the Securities and Exchange Commission on September 14, 2026.
- Filings detail fund holdings for VGT with the Securities and Exchange Commission.
- ImmunityBio must disclose its holdings in compliance with SEC filing requirements.